Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone
- 1 February 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (2) , 161-163
- https://doi.org/10.1128/aac.31.2.161
Abstract
A 400-mg dose of the trifluorinated quinolone Ro 23-6240 was administered orally to each of six healthy male volunteers, after which the concentrations of this agent in serum and cantharidin-induced inflammatory fluid were measured. Absorption was rapid, with a mean peak level in serum of 6.1 micrograms/ml, which was attained 0.71 h after administration. The elimination half-life in serum was 11.95 h. The agent penetrated the inflammatory fluid rapidly; the percent penetration was 89.7%. Urinary recovery of Ro 23-6240 was 58.6% by 72 h.This publication has 9 references indexed in Scilit:
- In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- The pharmacokinetics and tissue penetration of ofloxacinJournal of Antimicrobial Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of enoxacinAntimicrobial Agents and Chemotherapy, 1984
- Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983
- Norfloxacin disposition after sequentially increasing oral dosesAntimicrobial Agents and Chemotherapy, 1983
- The Influence of Protein Binding upon Tissue Fluid Levels of Six -Lactam AntibioticsThe Journal of Infectious Diseases, 1980
- Clinical PharmacokineticsNew England Journal of Medicine, 1975